{
  "id": 7341128,
  "title": "AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?",
  "url": "https://urgent.news/2026/09/14/abbvie-vs-crispr-therapeutics-which-healthcare-stock-is-a-better-buy",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-14T15:00:55.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/abbvie-vs-crispr-therapeutics-which-healthcare-stock-better-buy-2026"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsAbbVie generates billions in annual free cash flow and continues to expand its market share in immunology treatments.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}